Hypericin in photobiological assays: An overview

Photodiagnosis Photodyn Ther. 2021 Sep:35:102343. doi: 10.1016/j.pdpdt.2021.102343. Epub 2021 May 24.

Abstract

Hypericin is considered a potent photosensitizer for use in antitumor and antimicrobial photodynamic therapy (PDT). This review presents the primary biological results obtained with hypericin in photodynamic therapy applications, such as photodynamic cancer treatment, photoinactivation of microorganisms (PDI), tissue scarring, and photo diagnosis. We present a compilation of in vitro results that have been published thus far; for these studies, we highlight the hypericin concentration, light dose, and other experimental conditions to evaluate the efficiency of photodynamic treatment like cell death, cell viability, or cell proliferation. The results indicate that different hypericin phototoxicity levels can be observed according to the specific light dose and concentration. Furthermore, it was shown that cellular localization and cell death mechanisms (apoptosis and necrosis) are dependent on the cell type.

Keywords: Cell death; Photodynamic therapy; Photosensitizer; Phototoxicity.

Publication types

  • Review

MeSH terms

  • Anthracenes
  • Apoptosis
  • Cell Survival
  • Perylene* / analogs & derivatives
  • Perylene* / pharmacology
  • Photochemotherapy* / methods
  • Photosensitizing Agents / pharmacology
  • Photosensitizing Agents / therapeutic use

Substances

  • Anthracenes
  • Photosensitizing Agents
  • Perylene
  • hypericin